St Elizabeth Celebrates Cardiac Care Breakthrough with Dual-Chamber Pacemaker

St Elizabeth Celebrates Cardiac Care Breakthrough with Dual-Chamber Pacemaker

Doctors at St. Elizabeth Healthcare implant AVEIR DR Dual Chamber Leadless Pacemaker

Introduction

Doctors at the Florence Wormald Heart & Vascular Institute at St. Elizabeth Healthcare have achieved a major milestone by performing the first implantation of the AVEIR DR Dual Chamber Leadless Pacemaker (LP) System in the Greater Cincinnati region. This article aims to discuss the AVEIR DR LP system, how it works, its benefits, and the impact it is likely to have on cardiac treatment.

What is the AVEIR DR Dual Chamber Leadless Pacemaker?

The AVEIR DR Dual Chamber Leadless Pacemaker is a new device designed to treat abnormal or slow heart rhythms, also known as arrhythmia. It eliminates the need for leads or wires, which traditionally were used with pacemakers, and instead uses a leadless pacemaker. The device consists of two components; the AVEIR AR LP and the AVEIR VR LP. One of these components can be implanted initially and the other added later if needed to ensure both chambers of the heart are paced and sensed. This innovative design enables physicians to adjust treatment as patient needs evolve.

Benefits of AVEIR DR LP system

Unlike traditional pacemakers, the AVEIR DR Dual Chamber Leadless Pacemaker system does not require chest incisions for generator placement, which means no visible scarring. In addition, patients do not have any restrictions on arm movement, which improves their short-term recovery compared to a traditional pacemaker. Another benefit is that by eliminating the need for leads or wires, the AVEIR DR LP system also eliminates common complications associated with traditional pacemakers such as infection, lead fracture, and insulation problems.

The Procedure

The procedure for implanting the AVEIR DR Dual Chamber Leadless Pacemaker is relatively straightforward, and can be done on a same-day basis. For instance, Dr. Mohamad Sinno, a Cardiac Electrophysiologist at St. Elizabeth Healthcare conducted the procedure in April. The FDA approved the AVEIR DR LP system in 2023 for implantation. Patients receiving this system should be prepared for routine check-ups to monitor their pacemaker’s function and ensure its battery is running correctly.

The Impact of AVEIR DR on Cardiac Treatment

The AVEIR DR Dual Chamber Leadless Pacemaker is likely to have a significant impact on cardiac treatment in the future. It provides a unique approach to pacemaker treatment while eliminating most of the associated side effects. Furthermore, the leadless pacemaker simplifies the entire process of heart care and makes it possible for both chambers to be paced, when necessary.

Conclusion

The AVEIR DR Dual Chamber Leadless Pacemaker is a life-saving device that provides a groundbreaking approach to pacemaker treatment. With its innovative design, it eliminates common complications associated with traditional pacemakers, such as infection, lead fracture, insulation problems, skin erosion, and keloid formation. It’s exciting to see this device available for patients in the Greater Cincinnati region, and we can expect further expansion in the future.

Keywords

  • Atria leadless pacemaker
  • Ventricular leadless pacemaker
  • Abnormal heart rhythms
  • Pacemaker treatment
  • Cardiac Electrophysiology
  • Heart care
  • Heart complications
  • Cardiac treatment
  • St. Elizabeth Healthcare
  • FDA approval

Originally Post From https://nkytribune.com/st-elizabeth-marks-milestone-in-cardiac-care-with-new-dual-chamber-pacemaker/

Read more about this topic at
Innovations aim to halt pacemakers
UChicago scientists invent ultra-thin, minimally-invasive …

SoftBank Group Offers AI Data Analysis for Cancer Treatment on nippon.com

UK Patients to Receive $3.3 Million Hemophilia Gene Therapy for Free: Forbes